Nektar has said it will cut 70% of its workforce in the wake of the comprehensive failure in trials of its immuno-oncology candidate bempegaldesleukin, which was discontinued last week. The move ...
Ethical Web's previous CEO, Manfred Ebensberger, left the post for personal reasons. He remains a big supporter of the company and retains a keen interest in its progress.